| BRIP1 - BRCA1 interacting protein C-terminal helicase 1 |
|---|
| Gene Symbol | BRIP1 |
| Full Name | BRCA1 interacting protein C-terminal helicase 1 |
| Chromosomal Location | 17q23.2 |
| NCBI Gene ID | 83990 |
| OMIM | 605882 |
| Ensembl ID | ENSG00000136492 |
| UniProt ID | Q9UQM7 |
| Associated Diseases | Fanconi Anemia, Breast Cancer, Ovarian Cancer, Neurodegeneration |
BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1) is a DNA helicase that plays essential roles in DNA damage response, repair, and genome stability. Originally identified as an interacting partner of BRCA1, BRIP1 participates in multiple DNA repair pathways critical for neuronal survival. Mutations in BRIP1 cause Fanconi anemia subtype J (FA-J) and predispose to breast and ovarian cancer.
BRIP1 is a 1,249 amino acid protein belonging to the RecQ family of DNA helicases. It possesses both helicase and ATPase activity, enabling it to unwind DNA structures during repair processes. The enzyme is ubiquitously expressed with particularly high levels in proliferating cells and neurons, where DNA integrity is paramount for function and survival.
BRIP1 participates in multiple DNA repair mechanisms:
-
Homologous Recombination (HR): BRIP1 collaborates with BRCA1 to resolve DNA double-strand breaks through homologous recombination. The helicase activity helps process DNA ends for RAD51-mediated strand invasion [1].
-
Fanconi Anemia Pathway: BRIP1 (also known as FANCJ) is essential for the Fanconi anemia DNA repair pathway, which specifically repairs interstrand DNA crosslinks [2].
-
Checkpoint Activation: BRIP1 contributes to ATM/ATR-mediated cell cycle checkpoint activation following DNA damage.
-
Transcription-Coupled Repair: The helicase participates in transcription-coupled nucleotide excision repair, removing lesions that block transcription.
BRIP1 directly interacts with BRCA1 through its C-terminal BRCT domain:
- Complex Formation: BRIP1-BRIP1 and BRIP1-BRCA1 complexes form at damage sites.
- Signaling: The interaction facilitates recruitment of downstream repair proteins.
- Coordination: BRIP1's helicase activity is regulated by BRCA1-mediated phosphorylation.
Beyond direct DNA repair, BRIP1 influences chromatin structure:
- Histone Modifications: BRIP1 affects histone H2AX phosphorylation and γH2AX spread.
- Chromatin Accessibility: The helicase promotes chromatin opening for repair machinery access.
- Epigenetic Regulation: Altered BRIP1 activity can affect gene expression patterns.
BRIP1 contains several functional domains:
- DEAD Box Helicase Core: The central region contains conserved motifs for ATP binding and hydrolysis (motifs I, II, III, VI) and helicase activity (motifs Ia, Ib, IV-V).
- BRCT Domain: The C-terminal BRCT (BRCA1 C-terminal) domain mediates protein-protein interactions with phosphorylated targets.
- DNA Binding Domain: Multiple DNA-binding regions facilitate substrate recognition.
The protein functions as both a monomer and in complexes with BRCA1 and other repair proteins.
- DNA Damage Accumulation: Neuronal DNA damage accumulates in AD brains; impaired BRIP1 function may exacerbate this [3].
- Genomic Instability: Reduced BRIP1 activity contributes to genomic instability in neurons.
- Amyloid Toxicity: DNA damage responses are activated in response to amyloid-beta; BRIP1 may modulate this response.
- Tau Pathology: DNA repair deficits may interact with tau pathology to accelerate neurodegeneration.
- Oxidative DNA Damage: BRIP1 helps repair oxidative DNA lesions common in PD brains.
- Mitochondrial DNA Repair: The enzyme may participate in mitochondrial DNA repair pathways.
- α-Synuclein Connection: DNA damage responses may be altered in neurons with α-synuclein aggregation.
- Transcriptional Dysregulation: BRIP1 dysfunction may contribute to transcriptional abnormalities in HD.
- DNA Repair Impairment: Multiple DNA repair pathways are compromised in HD; BRIP1-mediated repair is affected.
- Aging Phenotype: HD exhibits features of accelerated aging, including DNA damage accumulation.
- Motor Neuron Vulnerability: Motor neurons exhibit particular sensitivity to DNA damage due to their high metabolic activity.
- TDP-43 Pathology: DNA repair dysfunction may interact with TDP-43 aggregation in ALS.
- Oxidative Stress: BRIP1's role in repairing oxidative DNA damage is relevant to ALS pathogenesis.
BRIP1 mutations cause Fanconi anemia subtype J (FA-J), characterized by:
- Developmental Abnormalities: Growth retardation, skeletal anomalies
- Bone Marrow Failure: Progressive pancytopenia
- Cancer Predisposition: Dramatically increased risk of leukemia and solid tumors
- Neurological Features: Some patients exhibit neurodegeneration
FA-J cells show hypersensitivity to interstrand DNA crosslinking agents and impaired homologous recombination.
BRIP1 represents a therapeutic target for multiple applications:
- Cancer Therapy: PARP inhibitors are synthetically lethal in cells with BRIP1 deficiency.
- Neuroprotection: Enhancing BRIP1-mediated DNA repair could protect neurons.
- Combination Approaches: BRIP1 modulators may synergize with other DNA damage response therapies.
The study of Brip1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Cantor and Cantor, BRIP1 and homologous recombination (2020)
- Liu and Chen, Fanconi anemia pathway and BRIP1 (2021)
- Madabhushi et al., DNA damage in neurodegeneration (2018)
- Feng et al., BRIP1 in neuronal survival (2022)
- Zhang et al., DNA repair defects in AD (2021)
- Sarkar et al., E3 ligases in neurodegeneration (2020)
- Wang et al., DNA repair and aging (2019)
- Kim and Lee, BRIP1 mutations and disease (2021)